541 related articles for article (PubMed ID: 28332701)
1. The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.
Kietzmann T; Petry A; Shvetsova A; Gerhold JM; Görlach A
Br J Pharmacol; 2017 Jun; 174(12):1533-1554. PubMed ID: 28332701
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of oxidative stress: translational opportunities.
Daiber A; Di Lisa F; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.
Daiber A; Di Lisa F; Oelze M; Kröller-Schön S; Steven S; Schulz E; Münzel T
Br J Pharmacol; 2017 Jun; 174(12):1670-1689. PubMed ID: 26660451
[TBL] [Abstract][Full Text] [Related]
4. New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.
Di Lisa F; Giorgio M; Ferdinandy P; Schulz R
Br J Pharmacol; 2017 Jun; 174(12):1690-1703. PubMed ID: 26990284
[TBL] [Abstract][Full Text] [Related]
5. Exercise, redox homeostasis and the epigenetic landscape.
Dimauro I; Paronetto MP; Caporossi D
Redox Biol; 2020 Aug; 35():101477. PubMed ID: 32127290
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species: key regulators in vascular health and diseases.
Chen Q; Wang Q; Zhu J; Xiao Q; Zhang L
Br J Pharmacol; 2018 Apr; 175(8):1279-1292. PubMed ID: 28430357
[TBL] [Abstract][Full Text] [Related]
7. ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello G; Knaus UG
Br J Pharmacol; 2017 Jun; 174(12):1704-1718. PubMed ID: 26758851
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
Woodward L; Akoumianakis I; Antoniades C
Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant effects of resveratrol in the cardiovascular system.
Xia N; Daiber A; Förstermann U; Li H
Br J Pharmacol; 2017 Jun; 174(12):1633-1646. PubMed ID: 27058985
[TBL] [Abstract][Full Text] [Related]
10. Stressing the (Epi)Genome: Dealing with Reactive Oxygen Species in Cancer.
Bhat AV; Hora S; Pal A; Jha S; Taneja R
Antioxid Redox Signal; 2018 Nov; 29(13):1273-1292. PubMed ID: 28816066
[TBL] [Abstract][Full Text] [Related]
11. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease.
Haslund-Vinding J; McBean G; Jaquet V; Vilhardt F
Br J Pharmacol; 2017 Jun; 174(12):1733-1749. PubMed ID: 26750203
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Modifications in Cardiovascular Aging and Diseases.
Zhang W; Song M; Qu J; Liu GH
Circ Res; 2018 Sep; 123(7):773-786. PubMed ID: 30355081
[TBL] [Abstract][Full Text] [Related]
14. The oxidative stress theory of disease: levels of evidence and epistemological aspects.
Ghezzi P; Jaquet V; Marcucci F; Schmidt HHHW
Br J Pharmacol; 2017 Jun; 174(12):1784-1796. PubMed ID: 27425643
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
Cirino G; Vellecco V; Bucci M
Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System.
Angelini F; Pagano F; Bordin A; Milan M; Chimenti I; Peruzzi M; Valenti V; Marullo A; Schirone L; Palmerio S; Sciarretta S; Murdoch CE; Frati G; De Falco E
Oxid Med Cell Longev; 2017; 2017():2712751. PubMed ID: 28607629
[TBL] [Abstract][Full Text] [Related]
17. Histone methylation and transcriptional regulation in cardiovascular disease.
Xu Y; Fang F
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):89-97. PubMed ID: 24801729
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on small molecules in cardiovascular diseases.
Wang X; Huang Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891
[TBL] [Abstract][Full Text] [Related]
19. OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: novel mechanisms for cardiovascular diseases.
Chen KC; Liao YC; Hsieh IC; Wang YS; Hu CY; Juo SH
J Mol Cell Cardiol; 2012 Mar; 52(3):587-95. PubMed ID: 22226905
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs Regulating Reactive Oxygen Species in Cardiovascular Diseases.
Gong YY; Luo JY; Wang L; Huang Y
Antioxid Redox Signal; 2018 Oct; 29(11):1092-1107. PubMed ID: 28969427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
